Abstract
Antibodies to human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) and to human T-cell leukemia virus (HTLV-1) were investigated by ELISA, Western blot and radioimmunoprecipitation (RIPA) assay in 318 sera (191 males and 127 females) obtained from syphilitic patients. The sera from 10% of the males and 3.1% of the females were positive for HIV-1. None of the sera contained antibodies to HIV-2. Antibodies to HTLV-1–2 were present in the sera of 7.1% of the males and 4.8% of the females who were seronegative for HIV. Five out of 24 (20.8%) HIV-1 positive subjects had antibodies to HTLV-1–2 as well.
Sera from another group of 58 syphilitic patients (38 males and 20 females in the Anti-Venereal Disease Department), seronegative for HIV-1 and HIV-2, who denied both i.v. drug abuse and blood transfusion, were investigated in the same manner. None of the males had antibodies to HTLV-1–2, while 2 females (10%) were positive.
Similar content being viewed by others
References
BassJ., ThomasL.L., vanOostveenJ.W., DaenenS. and SlaterR.M. (1985): T lymphoma associated with HTLV-1 outside the Carribbean and Japan. - Lancet ii: 338.
CatoskyD., RoseM., GooldenA.W.G., WhiteI.M., BourkasG., BrownellA.I., BlattnerW.A., GreavesM.F., GaltonD.A.G., McClauskeyD.R., LampertI., IrelandR., BridgesJ.M. and GalloR.C. (1982): Adult T-cell lymphoma-leukemia in blacks from the West Indies. - Lancet i: 639–646.
ClavelF., GuetardD., Brun-VezinetF., ChamaretS., ReyM.A., Santos-FerreiraM.O., LaurentA., KatlamaC., RouziouxC., KlatzmannD., ChampalimaudJ.L. and MontagnierL. (1986): Isolation of a new human retrovirus from West African patients with AIDS. -Science 233: 342–346.
DeRossi A., FranchiniG., AldoviniA., DelMistroA., Chieco-BianchiL., GalloR.C. and Wong-StaalF. (1986): Differential response to the cytopathic effect of human T cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-1. -Proc. Natl. Acad. Sci. USA 83: 4297–4301.
GessainA., BarinF. and VernantI.C. (1985): Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis in Africa. -Lancet ii: 407–409.
GoudsmitJ., deWolfF., van deWielB., SmitL., BakkerM., Albrecht-van LentN. and CoutinhoR.A. (1987): Spread of human T-cell leukemia virus (HTLV-1) in the Dutch homosexual community. - J. Med. Virol.23: 115–121.
HinumaY., NagataK., NakaiM., MatsumotoT., KinoshitaK.I., ShirakawaS. and MiyoshiI (1981): Adult T-cell leukemia: Antigens in an ATL cell line and detection of antibodies to the antigen in human sera. - Proc. Natl. Acad. Sci., USA 19: 6476–6480.
HinumaY., KomodaH., ChosaT., KondoT., KohakuraH., TakenakaT., KikuchiM., IchimaruM., YunakiK., MatsuoR., TakiuchiY., UchinoH. and HanaokaM. (1982): Antibodies to adult T-cell leukemia virus associated antigen (ATL) in sera from patients with ATL and controls in Japan: A nationwide seroepidemiologic study. - Int. J. Cancer 29: 631–635.
JacobsonS., RaineC.S., MingioloE.S. and McFarlinD. (1988): Isolation of an HTLV-1-like retrovirus from patients with tropical spastic paraparesis. - Nature 331: 540–543.
Koproski tH., DeFreitasE.C., HarperM.E., Sandberg-WollheimM., SheremataW.A., Robert-GuroffM., SaxingerC.W., FeinbergM.B., Wong-StaalF. and GalloR.C. (1985): Multiple sclerosis and human T-cell lymphotropic retroviruses. - Nature 318: 154–160.
KalyanaramanV.S., NarayananR., FeorinoP., RamseyR.B., PalmerE.L., ChorbaT., McDougalS., GetschellJ.P., HollowayB., HarrisonA.K., CabradillaC.D., TelferM. and EvattB. (1985): Isolation and characterization of a human T cell leukemia virus type II from a hemophilia-A patient with pancytopenia. - Embo J. 4: 1455–1460.
KalyanaramanV.S., SarngadharanM.G., Robert-GuroffM., MiyoshyI., BlaneyD., GoldeD. and GalloR.C. (1982): A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. - Science 218: 571–573.
LeeH., SwansonP., ShortyV.S., ZackJ.A., RosenblattJ.D. and ChenI.S.Y. (1989): High Rate of HTLV-II Infection in Seropositive IV Drug Abusers in New Orleans. - Science 244: 471–475.
LeeT.H., ColiganJ.E., McLaneM.F., SodroskiJ.G., PopovicM., Wong-StaalF., GalloR.C., HaseltineW. and EssexM. (1984): Serological cross-reactivity between envelope gene products of type I and type II human T-cell leukemia virus. - Proc. Nat. Acad. Sci., USA 81: 7579–7583.
LaemmliU.K. (1970): Cleavage of structural proteins during the assembly of the bead of bacteriophage T4.- Nature 227: 680–685.
Manca N., Caruso A., Bonfanti C., Savoldi E., LiVigniR., PiraliF., SapelliP.L., TuranoA. (1989): HTLV-1 seroprevalence in AIDS patients and in HIV-1 seropositive and seronegative subjects at risk for AIDS in Northern Italy. - Eur. J. Epidemiol. 5: 37–41.
ManzariV., GradiloneA., BarillariG., ZaniM., CollaltiE., PandolfiF., DeRossiG., LisoV., BabboP., Robert-GuroffM. and FratiL. (1985): HTLV-1 is endemic in Southern Italy: detection of the first infection cluster in a white population. - Int. J. Cancer 36: 557–559.
MiedemaF., TerpstraF., SmitJ.W., DaenenS., GerritsW., HedgeU., MatutesE., CatowskiD., GreavesM.F., MeliefC.J.M. (1984): Functional properties of neoplastic T cell lymphoma/leukemia patients from the Carribbean. - Blood 63: 477–481.
Morbidity and Mortality Weekly Report MMWR (1988): 37, 48: 736–747.
PoietsB.J., RuscettiF.W., GadzarAF., BunnP.A., MinnaJ.D. and GalloR.C. (1980): Detection and isolation of type C retrovirus particles from fresh and cocultured lymphocytes of a patient with cutaneous T cell lymphoma. - Proc. Natl. Acad. Sci., USA 77: 7415–7419.
PoietzB.J., RuscettiF.W., ReizM.S., KalyanaramanV.S. and GalloR.C. (1981): Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sezary T cell leukemia. - Nature 294: 268–271.
Premkumar ReddyE., Sandberg-WollheimN., Mettus R.V., RayP.E., DeFreitasE., KoprowskiH. (1989): Amplification and Molecular Cloning of HTLV-1 Sequences from DNA of Multiple Sclerosis Patients.- Science 243: 529–533.
Robert-GuroffM., NakaoY., NotakeK., ItoY., SliskiA. and GalloR.C. (1982): Natural antibodies to human retrovirus HTLV in a cluster of Japanese patients with adult T cell leukemia. - Science 215: 975–978.
Robert GuroffM., BlayneyD.W., SafaiB., LangeM., GelmanE.P., GuttermanJ.W., ManselP.W.A., GoedertJ.L., GroopmanJ.E., SteigbigelN.H., SidhuG.S., JohnsonJ.M., Friedman-KievA.E., DowningR., BayleyA.C. and GalloR.C. (1984): THLV-1 specific antibody in AIDS patients and others at risk. -Lancet ii: 128–131.
Robert-GuroffM., WeissS.H., GironJ.A., JenningsA.M., GinzburgH.M., MargolisI.B., BlattnerW.A. and GalloR.C. (1986): Prevalence of antibodies to HTLV-I,-II and -III in intravenous drug abusers from an AIDS endemic region. - J. Am. Med. Assoc. 255: 3133–3137.
TowbinH., StaehelinT. and GordonJ. (1979): Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. - Proc. Natl. Acad. Sci. USA 76: 50–54.
Wong-StaalF. and GalloR.C. (1985): The family of human T-lymphotropic leukemia viruses: HTLV-I as the cause of adult T cell leukemia and HTLV-III as the cause of acquired immunodeficiency syndrome. -Blood 65: 253–263.
ZackJ.A., CannA.J., LugoJ.P. and ChenI.S.Y. (1988): HIV-I production from infected peripheral blood T cells after HTLV-1 induced mitogenic stimulation. - Science 240: 1026–1029.